<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - BIIB</title>
<description>International Business News - BIIB</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Business, economic events for the coming week</title>
  <description>Major business events and economic events scheduled for the coming week (some dates are tentative): MONDAY, July 21</description>
    <link>http://www.ibtimes.com/articles/20080718/business-economic-events-for-the-coming-week.htm</link> 
  <pubDate>Fri, 18 Jul 2008 17:45:02 EDT</pubDate>
  </item>


  <item>
  <title>Movers roundup: Wachovia, Biogen Idec</title>
  <description>Among the stock activity stories for Tuesday, July 15, from AP Financial News: NEW YORK (AP)--Wachovia Corp. shares regained some of their losses Tuesday afternoon, following a steep decline earlier in the day after Oppenheimer &amp; Co. analyst Meredith Whitney cut her rating on the national bank.</description>
    <link>http://www.ibtimes.com/articles/20080715/movers-roundup-wachovia-biogen-idec.htm</link> 
  <pubDate>Tue, 15 Jul 2008 14:33:44 EDT</pubDate>
  </item>


  <item>
  <title>Biogen Idec shares rise on 2Q Rituxan sales</title>
  <description>Shares of biotechnology company Biogen Idec Inc. jumped Tuesday after its partner on the blockbuster drug Rituxan reported a surge in second-quarter sales.</description>
    <link>http://www.ibtimes.com/articles/20080715/biogen-idec-shares-rise-on-2q-rituxan-sales.htm</link> 
  <pubDate>Tue, 15 Jul 2008 19:41:33 EDT</pubDate>
  </item>


  <item>
  <title>Nasdaq 100 Leaders and Laggards: INFY WYNN UAUA</title>
  <description>The Nasdaq 100 index fell Friday as oil prices hit a fresh high and the broader market declined on concerns about Fannie Mae and Freddie Mac. The index, which includes 100 of the largest nonfinancial securities listed on the Nasdaq Stock Market, declined 28.69 points, or 1.6 percent, to 1,810.88. The broader Nasdaq composite fell 18.77 points to 2,239.08.</description>
    <link>http://www.ibtimes.com/articles/20080711/nasdaq-100-leaders-and-laggards-infy-wynn-uaua.htm</link> 
  <pubDate>Fri, 11 Jul 2008 17:40:00 EDT</pubDate>
  </item>


  <item>
  <title>Closing Glance: Biotechnology</title>
  <description>Shares of biotechnology companies closed mostly lower Friday with the broader market as investors focused on troubles at mortgage companies Fannie Mae and Freddie Mac and oil prices continued climbing.</description>
    <link>http://www.ibtimes.com/articles/20080711/closing-glance-biotechnology.htm</link> 
  <pubDate>Fri, 11 Jul 2008 16:14:39 EDT</pubDate>
  </item>


  <item>
  <title>Opening Glance: Biotechnology</title>
  <description>Shares of biotechnology companies opened mixed Friday as the broader market declined on troubles at government-backed mortgage companies Fannie Mae and Freddie Mac, and oil prices continued climbing.</description>
    <link>http://www.ibtimes.com/articles/20080711/opening-glance-biotechnology.htm</link> 
  <pubDate>Fri, 11 Jul 2008 09:55:27 EDT</pubDate>
  </item>


  <item>
  <title>New pharma ethics rules eliminate gifts and meals</title>
  <description>Drug company sales representatives will have to stop doling out coffee mugs and pens that push their products when they visit doctor's offices. But they can still sneak in the occasional free lunch.</description>
    <link>http://www.ibtimes.com/articles/20080711/new-pharma-ethics-rules-eliminate-gifts-and-meals.htm</link> 
  <pubDate>Fri, 11 Jul 2008 05:28:20 EDT</pubDate>
  </item>


  <item>
  <title>Closing Glance: Biotechnology</title>
  <description>Shares of biotechnology companies closed mixed Thursday as the broader market rose slightly on Dow Chemical's multibillion dollar buyout bid for rival Rohm and Haas helped offset concerns about the financial sector and energy costs.</description>
    <link>http://www.ibtimes.com/articles/20080710/closing-glance-biotechnology.htm</link> 
  <pubDate>Thu, 10 Jul 2008 16:25:30 EDT</pubDate>
  </item>


  <item>
  <title>Biogen Idec inspector confirms board elections</title>
  <description>An independent inspector confirmed Thursday that Biogen Idec Inc. shareholders elected director nominees during the company's annual meeting. The election, on June 19, was an upset for billionaire investor Carl Icahn, who tried to get a slate of three dissident nominees elected. His hope was to trigger a sale of the biotech company to a major pharmaceutical player.</description>
    <link>http://www.ibtimes.com/articles/20080710/biogen-idec-inspector-confirms-board-elections.htm</link> 
  <pubDate>Thu, 10 Jul 2008 10:29:26 EDT</pubDate>
  </item>


  <item>
  <title>Opening Glance: Biotechnology</title>
  <description>Shares of biotechnology companies opened higher Thursday with the broader market on better-than-expected monthly sales reports and Dow Chemical Co.'s $15 billion buyout offer for Rohm and Haas Co.</description>
    <link>http://www.ibtimes.com/articles/20080710/opening-glance-biotechnology.htm</link> 
  <pubDate>Thu, 10 Jul 2008 09:41:12 EDT</pubDate>
  </item>


  <item>
  <title>New pharma ethics rules eliminate gifts and meals</title>
  <description>Drug company sales representatives will have to stop doling out coffee mugs and pens that push their products when they visit doctor's offices. But they can still sneak in the occasional free lunch.</description>
    <link>http://www.ibtimes.com/articles/20080710/new-pharma-ethics-rules-eliminate-gifts-and-meals.htm</link> 
  <pubDate>Thu, 10 Jul 2008 17:32:34 EDT</pubDate>
  </item>


  <item>
  <title>Closing Glance: Biotechnology</title>
  <description>Shares of biotechnology companies closed mixed Wednesday as the broader market tumbled on rising oil prices and concerns over upcoming earnings reports in the technology and financial sectors.</description>
    <link>http://www.ibtimes.com/articles/20080709/closing-glance-biotechnology.htm</link> 
  <pubDate>Wed, 09 Jul 2008 16:33:52 EDT</pubDate>
  </item>


  <item>
  <title>Market Spotlight: Biotechnology Earnings Preview</title>
  <description>Biotech companies will likely be one of the few bright spots for investors this earnings season, as demand for essential medical treatments continues unabated despite the economic slowdown.</description>
    <link>http://www.ibtimes.com/articles/20080709/market-spotlight-biotechnology-earnings-preview.htm</link> 
  <pubDate>Wed, 09 Jul 2008 13:10:45 EDT</pubDate>
  </item>


  <item>
  <title>Opening Glance: Biotechnology</title>
  <description>Shares of biotechnology companies opened mixed Wednesday while the broader market slipped on rising oil prices. Here's how several key biotechnology stocks performed Wednesday:</description>
    <link>http://www.ibtimes.com/articles/20080709/opening-glance-biotechnology.htm</link> 
  <pubDate>Wed, 09 Jul 2008 10:03:29 EDT</pubDate>
  </item>


  <item>
  <title>Closing Glance: Biotechnology</title>
  <description>Shares of biotechnology companies closed higher Tuesday as analysts anticipate a mostly positive string of second-quarter earnings reports for key biotechnology companies in the coming weeks.</description>
    <link>http://www.ibtimes.com/articles/20080708/closing-glance-biotechnology.htm</link> 
  <pubDate>Tue, 08 Jul 2008 16:46:35 EDT</pubDate>
  </item>


  <item>
  <title>Opening Glance: Biotechnology</title>
  <description>Shares of biotechnology companies opened higher Tuesday as the broader market rose after Federal Reserve chairman Ben Bernanke said the central bank might extend its lending efforts to investment banks.</description>
    <link>http://www.ibtimes.com/articles/20080708/opening-glance-biotechnology.htm</link> 
  <pubDate>Tue, 08 Jul 2008 10:09:41 EDT</pubDate>
  </item>


  <item>
  <title>Closing Glance: Biotechnology ends mixed</title>
  <description>Shares of biotechnology companies closed mixed Monday as the broader market fell over a cautious economic outlook from a Federal Reserve official and the possibility of more troubles in the financial sector.</description>
    <link>http://www.ibtimes.com/articles/20080707/closing-glance-biotechnology-ends-mixed.htm</link> 
  <pubDate>Mon, 07 Jul 2008 16:37:17 EDT</pubDate>
  </item>


  <item>
  <title>Out of the Gate: Teva drops on Copaxone results</title>
  <description>Shares of Teva Pharmaceutical Industries Ltd. fell Monday after the company posted disappointing results from a higher-dose trial of multiple sclerosis drug Copaxone.</description>
    <link>http://www.ibtimes.com/articles/20080707/out-of-the-gate-teva-drops-on-copaxone-results.htm</link> 
  <pubDate>Mon, 07 Jul 2008 10:41:54 EDT</pubDate>
  </item>


  <item>
  <title>Opening Glance: Biotechnology</title>
  <description>Shares of biotechnology companies opened mixed Monday following the long holiday weekend, while the broader market gained ground as oil fell more than $5 a barrel. Early in the session, the Dow Jones Industrial average was up nearly 100 points.</description>
    <link>http://www.ibtimes.com/articles/20080707/opening-glance-biotechnology.htm</link> 
  <pubDate>Mon, 07 Jul 2008 09:43:29 EDT</pubDate>
  </item>


  <item>
  <title>Opening Glance: Biotech shares open mixed</title>
  <description>Shares of biotechnology companies opened mixed Thursday as the broader market rose after the Labor Department reported that the nation's unemployment rate held steady at 5.5 percent last month, easing concerns over a worsening job losses.</description>
    <link>http://www.ibtimes.com/articles/20080703/opening-glance-biotech-shares-open-mixed.htm</link> 
  <pubDate>Thu, 03 Jul 2008 09:39:14 EDT</pubDate>
  </item>


</channel>
</rss>